Delivery Order SPE2DB22D2214-SPE2DB25FS3PP
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,661.02 firm fixed price delivery order is for Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has an ultimate completion date of August 11, 2022 and was awarded on August 10, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,939.22 Firm Fixed Price Delivery Order is for the supply of Gilenya 0.5 mg capsules to support government healthcare programs. The award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,206.55 firm-fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules, a specialty medication used for the treatment of multiple sclerosis. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $53,496.73 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $25,848.52 firm fixed price delivery order is for the supply of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a part of the U.S. Department of Defense (DoD). The contract, valued at $8,002.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication, to support DoD and other government healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,489.25, is for the delivery of Gilenya 0.5 mg capsules. The award has an ultimate completion date of January 5, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,787.68, is for the delivery of Gilenya 0.5 mg capsules. The contract is a Firm Fixed Price delivery order with an ultimate completion date of April 26, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Gilenya 0.5 mg Capsule 30s to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,878.38, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 3, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. This contract is not associated with a set-aside designation. AmerisourceBergen holds a...